Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how gut microbiome dysfunction relates to atopic dermatitis (AD), a common chronic skin disease. It focused on subspecies-level changes rather than broad community shifts. The gut microbiome was analyzed by 16S rRNA gene sequencing and metagenome sequencing. Reference genomes from the Human Microbiome Project and the KEGG Orthology database supported functional analysis. Short-chain fatty acids in stool were measured by gas chromatography-mass spectrometry.
Who was studied?
The gut microbiome from 132 human subjects was analyzed. This included 90 patients with atopic dermatitis and the remaining subjects as comparators. Analyses used fecal samples for sequencing and short-chain fatty acid measurement. Participant ages and country were not reported.
What were the most important findings?
Enrichment of a specific subspecies of Faecalibacterium prausnitzii was strongly associated with atopic dermatitis. The disease microbiome was also enriched in genes for using nutrients released from damaged gut epithelium, reflecting a bloom of auxotrophic bacteria. Stool from patients showed decreased butyrate and propionate, both anti-inflammatory. This reflected an intraspecies shift reducing high butyrate and propionate producers, including those related to strain A2-165, whose lack is also implicated in Crohn disease.
What are the greatest implications of this study?
The results point to subspecies-level dysbiosis in a single dominant gut species as a feature of atopic dermatitis. Reduced butyrate and propionate could impair the gut epithelial barrier. The authors propose a feedback loop between F. prausnitzii dysbiosis and gut epithelial inflammation. This may drive chronic disease and aberrant TH2 immune responses to skin allergens. The design is associative, so causation is not established.